|
IGENE Biotechnology, Inc. - Comparative Business Analysis Snapshot
Business Description
IGENE Biotechnology, Inc.. The Group's principal activity is to develop, manufacture and market industrial microbiology and related biotechnology products. AstaXin (R) is the registered trademark of the Group. AstaXin is a natural source of astaxanthin, a pigment which imparts the characteristic red color to the flesh of salmon, trout, prawns and certain other kind of fish and shellfish. The Group's products are value added specialty biochemical products derived from abundant, inexpensive and renewable agricultural residues and wastes through fermentation, physical and chemical separation and related chemical and biochemical engineering technologies. The Group mainly operates in the United States.
Competitor Analysis
This analysis compares IGENE Biotechnology, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
